CP110 inhibitors are a specific class of chemical compounds designed to interact with the CP110 protein, which is primarily involved in regulating centrosome duplication and ciliogenesis within cells. Centrosomes play a crucial role in organizing the mitotic spindle during cell division, ensuring accurate chromosome segregation and cell fate determination. On the other hand, ciliogenesis involves the formation and maintenance of primary cilia, microtubule-based structures protruding from the cell surface, which have vital functions in signal transduction and sensory perception. CP110, as a key regulator in these processes, acts as a suppressor of centriole elongation, thereby preventing the formation of excessive centrioles during the cell cycle. In normal circumstances, CP110 is tightly regulated, but its dysregulation can lead to abnormal centriole amplification, which is often associated with various human diseases, including ciliopathies. CP110 inhibitors, through their specific binding to CP110, disrupt its function and consequently alter centrosome duplication and ciliogenesis dynamics.
By interfering with these fundamental cellular processes, these inhibitors can have profound effects on cell cycle progression, cell morphology, and intracellular signaling cascades. Research on CP110 inhibitors has shown promise in understanding the underlying molecular mechanisms that govern centrosome dynamics and ciliogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TGR-1202 | 1532533-67-7 | sc-507436 | 25 mg | $286.00 | ||
TGR-1202 is a inhibitor with potential anti-tumor effects by targeting proteins involved in centrosome duplication, including CP110. | ||||||